Nymox Pharmaceutical
NYMX
#8004
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-56.52%
Change (1 year)
Categories
Operating Margin for Nymox Pharmaceutical (NYMX)
Operating Margin as of April 2024 (TTM): -234,760.00%
According to Nymox Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is -234,760.00%. At the end of 2020 the company had an Operating Margin of -234,760.00%.
Operating Margin history for Nymox Pharmaceutical from 2001 to 2020
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2020 | -234,760.00% | 1969% |
| 2019 | -11,346.55% | 220.24% |
| 2018 | -3,543.14% | -40.9% |
| 2017 | -5,995.09% | 29.7% |
| 2016 | -4,622.39% | 613.3% |
| 2015 | -648.03% | 311.39% |
| 2014 | -157.52% | 7.79% |
| 2013 | -146.13% | -41.13% |
| 2012 | -248.25% | -19.92% |
| 2011 | -309.99% | -69.1% |
| 2010 | -1,003.25% | -18.57% |
| 2009 | -1,232.06% | 15.12% |
| 2008 | -1,070.21% | -11.89% |
| 2007 | -1,214.64% | 11.29% |
| 2006 | -1,091.46% | 31.41% |
| 2005 | -830.60% | -27.8% |
| 2004 | -1,150.41% | -46.87% |
| 2003 | -2,165.30% | 129.84% |
| 2002 | -942.08% | -27.31% |
| 2001 | -1,296.07% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.01% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -100.01% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -100.01% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -100.01% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 11.10% | -100.00% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.